High-throughput anaerobic screening for identifying compounds acting against gut bacteria in monocultures or communities
Nature Protocols,
Journal Year:
2023,
Volume and Issue:
19(3), P. 668 - 699
Published: Dec. 13, 2023
Language: Английский
Response, resistance, and recovery of gut bacteria to human-targeted drug exposure
Cell Host & Microbe,
Journal Year:
2024,
Volume and Issue:
32(6), P. 786 - 793
Published: June 1, 2024
Survival
strategies
of
human-associated
microbes
to
drug
exposure
have
been
mainly
studied
in
the
context
bona
fide
pathogens
exposed
antibiotics.
Less
well
understood
are
survival
non-pathogenic
and
host-associated
commensal
communities
variety
drugs
xenobiotics
which
humans
exposed.
The
lifestyle
microbial
commensals
within
complex
offers
a
ways
adapt
different
drug-induced
stresses.
Here,
we
review
responses
employed
by
gut
when
drugs-antibiotics
non-antibiotics-at
individual
community
level.
We
also
discuss
factors
influencing
recovery
establishment
new
structure
following
exposure.
These
key
stability
resilience
microbiome,
ultimately
overall
health
well-being
host.
Language: Английский
Nutrient competition predicts gut microbiome restructuring under drug perturbations
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 6, 2024
Human
gut
commensal
bacteria
are
routinely
exposed
to
various
stresses,
including
therapeutic
drugs,
and
collateral
effects
difficult
predict.
To
systematically
interrogate
community-level
of
drug
perturbations,
we
screened
stool-derived
Language: Английский
Emergent survival and extinction of species within gut bacterial communities
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 29, 2024
Synthetic
communities
can
help
uncover
metabolic
forces
shaping
microbial
ecosystems.
Yet,
in
case
of
the
gut
microbiota,
culturing
undefined
media
has
prevented
detection
dependencies.
Here
we
show,
using
chemically
defined
media,
how
species
survival
is
jointly
determined
by
supplied
resources
and
community
metabolism.
We
used
63
representative
bacterial
strains
varied
inoculum
compositions
to
assemble
stable
14
media.
Over
95%
showed
markedly
improved
or
diminished
performance
relative
monoculture
at
least
one
condition,
including
153
cases
(21%)
emergent
survival,
i.e.,
incapable
surviving
on
their
own
but
thriving
a
community,
252
(35%)
community-driven
extinctions.
Through
single
additions
exclusions,
metabolomic
analysis,
ecological
modelling,
demonstrate
inter-species
dependencies
–
especially
poor
are
mediated
biotic
nutrient
supply.
Our
results
highlight
communal
dividend
as
key
force
promoting
diversity.
Language: Английский
Long-term consequences of drug usage on the gut microbiome
Published: July 17, 2024
Abstract
Medication
usage
is
a
significant
contributor
to
the
inter-individual
variability
in
gut
microbiome.
However,
drugs
are
often
used
long-term
and
repeatedly,
notion
yet
unaccounted
for
microbiome
studies,
which
might
lead
underestimating
extent
of
drug
effects.
Recently,
we
others
showed
that
not
only
antibiotics
antidepressants
at
time
sampling
but
also
past
consumption
associated
with
This
effect
can
be
“additive”
-
more
used,
stronger
on
Here,
by
utilizing
electronic
health
records
Estonian
Microbiome
cohort
metagenomics
dataset
(n=2,509),
systematically
evaluate
effects
human-targeted
medications
We
show
microbiome,
example,
antibiotics,
psycholeptics,
antidepressants,
proton
pump
inhibitors,
beta-blockers
detectable
several
years
after
usage.
Furthermore,
analyzing
subcohort
(n=328)
measured
similar
changes
occur
treatment
initiation,
possibly
indicating
causal
Language: Английский
Off-purpose activity of industrial and agricultural chemicals against human gut bacteria
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 5, 2024
Abstract
Contamination
by
industrial
and
agricultural
chemicals
like
pesticides
are
a
cause
of
great
concern
due
to
the
risk
human
environmental
health.
While
these
often
considered
have
restricted
activity
labelled
as
such,
there
concerns
over
broader
toxicity
range.
Here
we
report
impact
1076
pollutants
spanning
diverse
chemistries
indicated
applications
on
22
prevalent
commensal
gut
bacteria.
Our
systematic
investigation
uncovered
588
interactions
involving
168
chemicals,
majority
which
were
not
previously
reported
antibacterial
properties.
Fungicides
showed
largest
with
circa
30%
exhibiting
anti-commensal
We
find
that
sensitivity
chemical
across
species
surprisingly
correlates
human-targeted
drugs,
suggesting
common
susceptibility
mechanisms.
Using
genome-wide
chemical-genetic
screen,
identified
membrane
transport
fatty
acid
metabolism
major
modulators
off-target
chemicals.
Mutants
resistance
include
those
defective
in
producing
human-health-relevant
metabolites
branched
short-chain
acids,
indicating
chronic
exposure
could
lead
selection
against
production
beneficial
metabolites.
Toxicokinetic
modelling
suggested
bacteria
be
used
more
sensitive
vitro
indicators
for
than
animal
models.
Together,
our
data
uncovers
widespread
Impact
structure
function
microbiota
should
therefore
assessing
safety.
Language: Английский
Non-antibiotic drugs break colonization resistance against pathogenicGammaproteobacteria
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: Nov. 6, 2023
Summary
Non-antibiotic
drugs
can
alter
the
composition
of
gut
microbiome,
with
largely
undefined
implications
for
human
health.
Here
we
compared
susceptibility
commensal
and
pathogenic
bacteria
to
non-antibiotic
found
that
pathogens
show
higher
drug
resistance,
which
could
favor
their
expansion
after
treatment.
We
then
developed
a
model
system
screen
drug-microbiome
interactions
increase
risk
enteropathogenic
infections.
Approximately
35%
>50
tested
increased
abundance
Salmonella
Typhimurium
in
synthetic
stool-derived
microbial
communities.
This
was
due
direct
effects
non-antibiotics
on
individual
commensals,
altered
within
communities
potential
exploit
different
metabolic
niches.
favored
vitro
also
promoted
other
enteric
loads
gnotobiotic
conventional
mice.
These
findings
may
inform
future
strategies
control
pathogen
proliferation
assess
microbiota-drug-pathogen
risks
infection.
Language: Английский
Proton-pump inhibitors increaseC. difficileinfection risk by altering pH rather than by affecting the gut microbiome based on a bioreactor model
Julia Schumacher,
No information about this author
Patrick Müller,
No information about this author
Johannes Sulzer
No information about this author
et al.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 10, 2024
Abstract
Clostridioides
difficile
infections
often
occur
after
antibiotic
use,
but
they
have
also
been
linked
to
proton-pump
inhibitor
(PPI)
therapy.
The
underlying
mechanism—whether
infection
risk
is
due
a
direct
effect
of
PPIs
on
the
gut
microbiome
or
changes
in
gastrointestinal
pH—has
remained
unclear.
To
disentangle
both
possibilities,
we
studied
impact
omeprazole
and
pH
key
members
human
stool-derived
microbial
communities
from
different
donors
vitro
.
We
then
developed
custom
multiple-bioreactor
system
grow
model
community
chemostat
mode
tested
effects
exposure,
changes,
their
combination
C.
growth
within
this
community.
Our
findings
show
that
significantly
affect
community’s
biomass
abundances
strains,
leading
increased
However,
treatment
alone
did
not
result
such
effects.
These
imply
higher
following
therapy
probably
because
alterations
rather
than
interaction
between
drug
microbiome.
This
understanding
paves
way
for
reducing
risks
Language: Английский
Emergent metabolic interactions in resistance toClostridioides difficileinvasion
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 30, 2024
Commensal
gut
bacteria
are
key
contributors
to
the
resilience
against
pathogen
invasion.
This
is
exemplified
by
success
of
fecal
microbiota
transplantation
in
treating
recurrent
Clostridioides
difficile
infection.
Yet,
characteristics
communities
that
can
confer
colonization
resistance
and
underlying
mechanisms
remain
largely
unknown.
Here
we
use
a
synthetic
community
14
commensal
uncover
inter-species
interactions
metabolic
pathways
underpinning
emergent
C.
We
challenged
this
as
well
fecal-matter-derived
with
antibiotic
treatment
continuous
flow
bioreactor.
Using
generalized
Lotka-Volterra
genome-scale
modelling,
identified
between
Escherichia
coli
Bacteroides/Phocaeicola
sp.
pathogen's
suppression.
Metabolomics
analysis
further
revealed
fructooligosaccharide
metabolism,
vitamin
B3
biosynthesis,
competition
for
Stickland
metabolism
precursors
contribute
Analysis
metagenomics
data
from
patient
cohorts
clinical
trials
attested
vivo
relevance
ratio
Bacteroides
successful
resistance.
The
latter
was
found
be
much
stronger
discriminator
than
commonly
used
alpha
diversity
metrics.
Our
study
uncovers
microbial
implications
rational
design
bacteriotherapies.
Language: Английский
Microbial risks associated with microplastics in the food chain and possible control measures (literature review). Part 1. Dietary intake and influence on the gut microbiota
Hygiene and Sanitation,
Journal Year:
2023,
Volume and Issue:
102(12), P. 1334 - 1347
Published: Dec. 28, 2023
Environmental
contamination
by
polymer
wastes
and
microplastics
(MPs)
has
recently
become
important
for
health
care,
due
to
the
emergence
of
a
lot
evidence
that
MPs
affect
living
organisms,
including
humans.
commonly
presented
in
drinking
water
various
groups
food
products,
are
found
human
stool,
colon
tissue,
blood
samples.
When
orally
ingested,
first
object
their
interaction
with
organism
is
gastrointestinal
microbiota.
Considering
essential
importance
intestinal
microbiota
health,
study
negative
consequences
such
contact
becomes
very
important.
The
results
“in
vitro”
vivo”
experimental
studies
summarized
review
indicate
have
effects
on
microbial
community
composition
barrier
state,
themselves
subject
degradation
tract.
“In
studies,
entry
into
intestine
accompanied
an
increase
α-diversity
microbiota,
presumably
foreign
microorganisms
attached
particles,
those
as
part
biofilms
formed
surfaces.
Competing
representatives
normal
flora,
these
able
enzymatically
degrade
or
overcome
mucosal
barrier.
Simultaneously
biofilm
matrix
associate
mucus
provides
particles
retention
mucin
layer
direct
apical
epitheliocytes.
This
leads
irritation,
local
inflammation,
damage
biotransformation
products
can
also
systemically
host
organism,
translocating
from
bloodstream.
emphasizes
identify
characterize
risks
associated
intake
food,
assessing
pathways
necessary.
Language: Английский